A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

Clinical trial NCT00734097 · COMPLETED

Trial details

NCT number: NCT00734097
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2007-11-01
Primary completion: 2008-10-01
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.